Treatment of Trichomonas vaginalis typically involves using nitroimidazoles (such as metronidazole and tinidazole). Some T. vaginalis strains have become resistant to these drugs, so the development of new drugs is necessary. Clinical samples were taken from 80 males and 70 females (aged 17-45). The sensitivity of T. vaginalis in these samples to CGNC (100, 200, 300 and 500 mg/mL) and metronidazole (10, 15, 25 and 50 µg/mL) was evaluated. All 10 isolates were sensitive to at least one concentration of CGNC. Three strains were sensitive (all cells were killed) to 100 mg/mL CGNC, while there was a decrease in the number of Trichomonas present in the other samples when compared with the control. Six strains were sensitive to 200 mg/mL CGNC, while those strains that grew in the presence of CGNC showed a reduction in numbers when compared with the control. Nine strains were sensitive to 300 mg/mL CGNC. The strain not sensitive to 300 mg/mL CGNC showed a decrease in the number of Trichomonas present (<10 2 cells/mL) when compared to the control (10 4 cells/mL). All strains were sensitive to 500 mg/mL CGNC. Three strains (one motile and two non-motile) were sensitive to all concentrations of CGNC and one of the non-motile strains was resistant (MIC 50 µg/mL) to metronidazole. The other two strains were moderately resistant (MIC 15 and 25 µg/mL) to metronidazole. Of the 10 Trichomonas strains, four were resistant to metronidazole (MIC 50 µg/mL) and sensitive to at least one concentration of CGNC. CGNC may be used as a treatment for T. vaginalis infections and should be considered for clinical strains resistant to metronidazole.
The emergence of antibiotic resistance to conventional drugs and treatments is a common public health problem. The World Health Organization reports that each year there are 276 million new cases of trichomoniasis, a sexually transmitted infection caused by the flagellated protozoan, Trichomonas vaginalis [1, 2] . Treatment of T. vaginalis typically involves using nitroimidazoles (such as metronidazole and tinidazole). Unfortunately, some T. vaginalis strains have become resistant to these drugs, so the development and search for new drugs is necessary.
Resistance to metronidazole and indeed, cross-resistance to metronidazole and other nitroimadazoles such as tinidazole, has been observed in T. vaginalis strains [3, 4] . Metronidazole resistance may result in the need for higher doses of metronidazole to treat the infection or prolonged therapy, which in turn may lead to problems with a patient's tolerance to increased doses [5, 6] . In some cases, treatment has failed after repeated therapy with this drug [3] .
Several reports suggest that the use of metronidazole causes side effects including hypersensitivity (such as uriticaria or hives and facial oedema), nausea, gastrointestinal problems and in extreme cases, neurotoxicity [7] [8] [9] [10] [11] . Similar short-term adverse effects have also been noted with tinidazole, although fewer side effects were reported with this drug [12, 13] .
Studies have shown that a wide variety of plants and their parts exhibit antimicrobial, antifungal, antiviral and anti-inflammatory properties [14] [15] [16] [17] . Preparations from pine and spruce needles have been used as treatments for colds, for anaemia and in cases of vitamin deficiencies [18] .
Conifer Green Needle Complex (CGNC; also known as Bioeffective®A) is a complex substance obtained from green verdure of Pinus sylvestris and Picea abies (L) Karst. CGNC contains chlorophyll derivatives, carotenoids, vitamins A, E, and K, phytosterols, polyprenols, squalene, sodium salts of fatty and resin acids, and essential oils including natural antibiotics (phytoncides) [19] . Diterpene resin acids have been shown to exhibit antimicrobial and antimycotic activity [14, 20, 21] . In particular, diterpene resin acids such as abietic and pimaric acids have demonstrated antimicrobial activity against methicillin-resistant Staphylococcus aureus [21] and Gram-positive bacteria [20] and growth-inhibitory effects on fungi [14] .
Medicinal plants and compounds from plants have also shown antitrichomonal activity [22, 23] . Several group of phytochemicals such as terpenes, β-glycosides, saponins, essential oils and alkaloids inhibit T. vaginalis [23, 24] . CGNC has antioxidant properties [25] and antimicrobial activities [19, 20] and has been shown to suppress Helicobacter pylori in vitro and in vivo [26] [27] [28] [29] .
In this study, we present results demonstrating the anti-protozoal activity of CGNC on T. vaginalis isolated from patients. We also present results comparing the effects on T. vaginalis of CGNC to the commonly used drug, metronidazole.
All of the 10 isolates were sensitive (all Trichomonas cells were killed) to at least one concentration of CGNC. Three strains were sensitive to 100 mg/mL, while there was a decrease in the number of Trichomonas present in the other samples when compared with the control (Table 1) . Six strains were sensitive to 200 mg/mL CGNC, while those strains that grew in the presence of CGNC showed a reduction in numbers when compared with the control (Table 1) .
Nine strains were sensitive to 300 mg/mL CGNC. The strain not sensitive to 300 mg/mL CGNC showed a decrease in the number of Trichomonas present (<10 2 cells/mL) when compared to the control (10 4 cells/mL) ( Table 1 ). All strains were sensitive to the highest concentration (500 mg/mL) of CGNC (Table 1) .
Three strains (one motile and two non-motile) were sensitive to all concentrations (100, 200, 300 and 500 mg/mL) of CGNC ( Table 1) . Of these, one of the non-motile strains was resistant (MIC 50 µg/mL) to metronidazole ( Table 1 ). The other two strains were moderately resistant (MIC 15and 25 µg/mL) to metronidazole ( Table 1) .
Of the 10 Trichomonas strains tested, four were resistant to metronidazole (MIC 50 µg/mL). All of these resistant strains were sensitive to at least one concentration of CGNC ( Table 1) .
As an aside, there was an imbalance or disruption of the microbial flora (dysbacteriosis) in patients that was caused by the use of antibiotics for the treatment for T. vaginalis infections. CGNC had an antibacterial effect on the microbial flora in samples obtained from patients who had dysbacteriosis (data not shown).
The bioactive components of medicinal plants have been shown to affect the viability of bacteria and anti-protozoal activity without the resultant resistance seen with the use of conventional medications [21, 30, 31 ]. An added benefit of using medicinal plants and their components is the low or non-existence of toxic side effects. The results from this study demonstrate that CGNC has an antitrichomonal effect. CGNC suppressed growth of T. vaginalis at 300 mg/mL, killed this organism at 500 mg/mL and killed some T. vaginalis strains that were resistant to metronidazole (Table 1) .
Resin acids have been found to play a role in antibacterial, antifungal and anti-protozoal activity. Diterpene resin acids such as abietic and pimaric acids have shown antibacterial activity including against methicillin-resistant Staphylococcus aureus [32] and activity against the protozoan parasite, Leishmania [33] as well as other unicellular eukaryotic parasites [34] [35] [36] . Resin acids in CGNG played a role in the anti-trichomonal activity, although at this stage, the mechanism of action of CGNC against Trichomonas is not known. Further work is required to elucidate the biochemical interactions of CGNC.
The results obtained in this study indicate that CGNC may be used as a treatment for T. vaginalis infections and further studies are warranted. 
Experimental

Conifer Green Needle Complex (CGNC):
The preparation of Conifer Green Needle Complex (CGNC) has been previously described [19] . CGNC is a dark-green, almost black, slightly alkaline (pH 8-9), viscous, aqueous-based paste comprising several hundred components. CGNC (as provided by Prenolica Limited, formerly Solagran Limited) is available in Australia, where it is approved by the TGA for use as a therapeutically active ingredient in listed oral and topical medicines.
Test substances -Conifer Green Needle Complex (CGNC;
Bioeffective® A), and metronidazole: The CGNC (batch No. AUST L34782, March 2009; Vyshniyvolochek, Russia) used in this study was manufactured by Prenolica Limited (formerly Solagran Limited). CGNC was provided as a sterile substance and diluted in sterile, distilled water at 56°С. The concentration of the CGNC solution was 1000 mg/mL. This initial solution was diluted to concentrations of 100, 200, 300 and 500 mg/mL, which were then used in the experiments with T. vaginalis. Metronidazole (AKOS, Sintez AKO, Russia) was used as the comparator drug. The original concentration of metronidazole was 50 mg/mL. The initial solution was diluted with liquid media to concentrations of 10, 15, 25 and 50 µg/mL, which were then used in the experiments with amistigote forms of T. vaginalis. The same concentration range was used for the actively mobile strains of Trichomonas.
T. vaginalis isolates:
Clinical T. vaginalis isolates from patients were cultured in liquid media (MIT®) (Department of New Technologies, Pasteur Institute, St Petersburg, Russia). Ten isolates were chosen for use in the experiments with CGNC and metronizadole. Three were actively motile, and seven were Sensitivity of Trichomonas vaginalis to CGNC Natural Product Communications Vol. 14 (1) 2019 149 amastigote forms. Isolates were also chosen on the basis of their ability to grow in the culture medium.
Sensitivity of T. vaginalis to CGNC:
A 0.5 mL solution containing 100, 200, 300 or 500 mg/mL of CGNC was added to 4 mL of culture media in a test tube. An inoculum (0.5 mL) of motile T. vaginalis made up in sterile saline and containing at least 10 4 cells/mL was also added to the test tube.
The presence of live and motile trophozoites was determined by microscopic examination ( 600 magnification). Motile trophozoites were identified by their shape, the presence of a nucleus and the presence of granules and vacuoles in their cytoplasm. Amistogotes had diffuse granules and the nucleus was not easily distinguished. The number of trophozoites per mL was determined using a counting chamber.
A test tube containing culture medium and Trichomonas, but without CGNC was used as a control. A layer of vaseline oil was added to each test tube to create anaerobic conditions. The test tubes were then incubated at 37 °C and checked at 48 and 96 hours.
There were three repeats for each Trichomonas strain at each concentration.
For the experiments with the amistogote forms of T. vaginalis, lysis of the trophozoites was used as an indicator of sensitivity to CGNC.
Sensitivity of T. vaginalis to metronidazole:
To test the sensitivity of the actively motile forms of T. vaginalis to metronidazole, ten-fold serial dilutions of metronidazole were made resulting in concentrations ranging from 0.25 µg/mL to 1000 µg/mL (1 mg/mL). The inoculum (0.5 mL) was made up in sterile saline and contained at least 10 4 cells/mL of Trichomonas. In these experiments, the inoculum contained at least 90% of motile trophozoites. A test tube containing culture medium and Trichomonas, but without metronidazole was used as a control. There were three repeats for each Trichomonas strain at each concentration.
The sensitivity of T. vaginalis to metronidazole was determined using the minimum inhibitory concentration (MIC), which was defined as the concentration where all the trophozoites became nonmotile. The Trichomonas isolates were considered to be resistant to metronidazole at >25 µg/mL, when the trophozoites became nonmotile.
For the experiments with the amistogote forms of T. vaginalis, a 0.5 mL solution containing 10, 15, 25 or 50 mg/mL metronidazole was added to 4 mL of culture media in a test tube. An inoculum (0.5 mL) of T. vaginalis made up in sterile saline and containing at least 10 4 cells/mL was also added to the test tube. A test tube containing culture medium and Trichomonas, but without metronidazole was used as a control.
The sensitivity of T. vaginalis to metronidazole was determined using the minimum inhibitory concentration (MIC), which was defined as the concentration where lysis of the trophozoites occurred. The Trichomonas isolates were considered to be resistant to metronidazole at >25 µg/mL, when lysis of the trophozoites occurred.
